Selenious Acid

CHEMBL2009089 Phase 4 承認済み Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
129.0 g/mol
LogP
Phase
4

Selenious acid is an inorganic selenium compound used as a dietary selenium supplement in parenteral nutrition formulations to prevent selenium deficiency in patients unable to receive oral nutrition. Selenium is an essential trace element required for the biosynthesis of selenoproteins including glutathione peroxidases and thioredoxin reductases, which protect cells from oxidative damage. Selenium deficiency has been associated with increased cancer risk, particularly ovarian and prostate cancers, leading to its investigation as a chemopreventive agent.

分子量

128.9900 g/mol

TPSA

57.50 Ų

治療領域

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=[Se](O)O

InChI

InChI=1S/H2O3Se/c1-4(2)3/h(H2,1,2,3)

Molecular Formula

H2O3Se

HBD / HBA

2 / 3

回転可能結合数

0

重原子数

4

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

Selenious acid is an inorganic selenium compound used as a dietary selenium supplement in parenteral nutrition formulations to prevent selenium deficiency in patients unable to receive oral nutrition. Selenium is an essential trace element required for the biosynthesis of selenoproteins including glutathione peroxidases and thioredoxin reductases, which protect cells from oxidative damage. Selenium deficiency has been associated with increased cancer risk, particularly ovarian and prostate cancers, leading to its investigation as a chemopreventive agent.

Yes, Selenious Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2009089. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 1091. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.